14^th International Symposium on Hodgkin Lymphoma

Personalized RTx: Focus on RTx Techniques and Late Effect Prediction Models
- DavidCutter Oxford
Just PD1-Inhibition? Early Insights from the GHSG INDIE Trial
- Paul J.Bröckelmann Cologne
Debate: Should Novel Agents Be Integrated Into the Frontline Treatment of Early Stage Low Risk HL Patients?
- GrahamCollins Oxford
- CatherineDiefenbach New York
Oral Abstract Presentations

15:15–16:45

Satellite Symposium

Satellite Symposium 2

17:00–18:30

Main Program

Opening Ceremony with Keynote Lecture & Awards

Keynote Lecture: Changing treatment paradigms in B cell Lymphoma
- GillesSalles New York

18:30–20:00

Main Program

Poster Session & Welcome Reception

Sunday 04.10.2026

Scientific Session Satellite Symposium Main Program Workshop

Export calendar

08:00–09:15

Scientific Session 3

HL in Children and Adolescents

ChristineMauz-Körholz Gießen
JamieFlerlage Memphis

Treatment Evolution in Pediatric Hodgkin Lymphoma: From Research to Real-World Impact
- MaurizioMascarin Aviano
Precision Medicine in Pediatric HL / Harmonized Pediatric HL Protocol in South Africa
- JenniferGeel Johannesburg
Oral Abstract Presentations

08:00–10:00

Workshop 3

Closed Workshop on Grassroot Initiative in Classic Hodgkin Lymphoma

Separate registration required

RanjanaAdvani Stanford
Peter OmondiOyiro
PeterBorchmann Cologne

09:30–10:30

Satellite Symposium

New concepts for the treatment of B-cell lymphomas

DLBCL – The current and future role of ADCs in the context of T-cell engaging therapies
- BjörnChapuy Berlin
cHL – Treatment strategies for PD-1 inhibition in the relapsed / refractory setting
- Bastianvon Tresckow Essen

10:45–12:15

Scientific Session 4

Translating ctDNA into clinical routine

SvenBorchmann Cologne
MargaretShipp Boston

Circulating Tumor DNA: New insights from the SWOG S1826 study.
- MargaretShipp Boston
Circulating Tumor DNA Analysis for Classification and MRD Assessment – Experience of the German Hodgkin Study Group
- SvenBorchmann Cologne
Workshop Report
- ChristianSteidl Vancouver
Oral Abstract Presentations

13:00–14:00

Scientific Session 5

Biology & Pathology

ChristianSteidl Vancouver
WolframKlapper Kiel

The Biology of HRS Cells
- RalfKüppers Essen
Novel Insights Into the Microenvironment of Hodgkin Lymphoma
- TomohiroAoki Toronto
Oral Abstract Presentations

14:15–15:45

Satellite Symposium

Satellite Symposium 4

16:00–17:30

Scientific Session 6

Evaluating Late Effects of Contemporary Treatments - Competing Risks & Novel Approaches
- CarolineDietrich Stockholm
Uncertainties with Anti-PD1 & irAE in the First-Line Setting
- Paul J.Bröckelmann Cologne
In Conversation with GHSG Patient Representatives: Building a Bridge Between Cancer Treatment and Everyday Life – Challenges After Lymphoma
- KarolinBehringer Cologne
- GHSGpatient representatives
Oral Abstract Presentations

17:45–19:15

Scientific Session 7

Advanced Stages

MarkHertzberg Randwick
GrahamCollins Oxford
PhilippeArmand Boston

Unmet Needs and Future Perspectives with BrECADD: Improving Outcomes of HD21
- JustinFerdinandus Cologne
Unmet Needs and Future Perspectives with Nivo-AVD: Unanswered Questions from SWOG S1826
- AlexHerrera Duarte
Oral Abstract Presentations

Monday 05.10.2026

Scientific Session Satellite Symposium Main Program Workshop

Export calendar

08:00–09:15

Scientific Session 8

Special Cases & Situations

JoséeZijlstra Amsterdam
Paul J.Bröckelmann Cologne

HL in Pregnancy
- Anne-SophieRobertz Köln
Critical Organ Failure at Presentation
- HishanTharmaseelan Cologne
Anti-PD1 Tx in Pre-Existing Autoimmune Disease
Workshop Report “Grassroot Initiative in Classic Hodgkin Lymphoma”
- RanjanaAdvani Stanford
- Peter OmondiOyiro

09:30–10:30

Scientific Session 9

NLPHL

WolframKlapper Kiel
RichardHoppe Stanford

Clinical Implications of Growth Patterns
- DennisEichenauer Cologne
Treatment Strategies
- JamieFlerlage Memphis
Oral Abstract Presentations

10:45–12:15

Scientific Session 10

Relapsed & Refractory HL

Craig H.Moskowitz New York
AnnaSureda Barcelona

2L Treatment of HL in Era of Novel Agents
- AlisonMoskowitz New York
Revisiting the Role of Stem Cell Transplantation in rrHL
- Bastianvon Tresckow Essen
Unmet Needs and Novel Treatment Approaches in >3L
- MartinHutchings Copenhagen
Oral Abstract Presentations

12:15–13:00

Main Program

Best of ISHL14

Best of ISHL14
- RanjanaAdvani Stanford
Farewell
- PeterBorchmann Cologne

Ranjana Advani
radvani@stanford.edu
Stefan Alig
stefan.alig@med.uni-muenchen.de
- 03.10., 08:30–11:00, Workshop on ctDNA in HL (Chair)
Tomohiro Aoki
tomohiro.aoki@uhn.ca
- 04.10., 13:00–14:00, Biology & Pathology (Speaker)
Philippe Armand
Philippe_Armand@dfci.harvard.edu
- 04.10., 17:45–19:15, Advanced Stages (Chair)
Igor Aurer
- 03.10., 08:30–11:00, EHA-LYG/GHSG Joint Session: EHA Clinical Practice Guidelines in Lymphoid Malignancies - From Recommendations to Patient Care (Chair)
Karolin Behringer
karolin.behringer@uk-koeln.de
- 04.10., 16:00–17:30, Living Beyond Lymphoma (Speaker)
Peter Borchmann
peter.borchmann@uk-koeln.de
- 04.10., 08:00–10:00, Closed Workshop on Grassroot Initiative in Classic Hodgkin Lymphoma (Chair)
- 05.10., 12:15–13:00, Best of ISHL14 (Speaker)
Sven Borchmann
sven.borchmann@uk-koeln.de
- 03.10., 08:30–11:00, Workshop on ctDNA in HL (Chair)
- 04.10., 10:45–12:15, Translating ctDNA into clinical routine (Chair, Speaker)
Paul J. Bröckelmann
paul.broeckelmann@uk-koeln.de
Max Büttner
- 04.10., 16:00–17:30, Living Beyond Lymphoma (Chair)
Björn Chapuy
bjoern.chapuy@charite.de
- 04.10., 09:30–10:30, New concepts for the treatment of B-cell lymphomas (Speaker)
Graham Collins
Graham.Collins@ouh.nhs.uk
- 04.10., 17:45–19:15, Advanced Stages (Chair)
- 03.10., 13:30–15:00, Early Stages (Speaker)
David Cutter
david.cutter@ndph.ox.ac.uk
- 03.10., 13:30–15:00, Early Stages (Speaker)
Catherine Diefenbach
catherine.diefenbach@nyumc.org
- 03.10., 13:30–15:00, Early Stages (Chair, Speaker)
Caroline Dietrich
caroline.dietrich@ki.se
- 04.10., 16:00–17:30, Living Beyond Lymphoma (Speaker)
Hans Theodor Eich
hans.eich@ukmuenster.de
- 03.10., 08:30–11:00, Individualization of Radiation Therapy for Hodgkin Lymphoma (Chair)
- 03.10., 13:30–15:00, Early Stages (Chair)
Dennis Eichenauer
dennis.eichenauer@uk-koeln.de
- 05.10., 09:30–10:30, NLPHL (Speaker)
Justin Ferdinandus
justin.ferdinandus@uk-koeln.de
- 04.10., 17:45–19:15, Advanced Stages (Speaker)
Jamie Flerlage
jamie.flerlage@stjude.org
- 04.10., 08:00–09:15, HL in Children and Adolescents (Chair)
- 05.10., 09:30–10:30, NLPHL (Speaker)
Alexander Fosså
aff@ous-hf.no
- 04.10., 16:00–17:30, Living Beyond Lymphoma (Chair)
Jennifer Geel
Jennifer.Geel@wits.ac.za
- 04.10., 08:00–09:15, HL in Children and Adolescents (Speaker)
Alex Herrera
aherrera@coh.org
- 04.10., 17:45–19:15, Advanced Stages (Speaker)
Mark Hertzberg
mhertzberg10@gmail.com
- 04.10., 17:45–19:15, Advanced Stages (Chair)
Richard Hoppe
richard.hoppe@stanford.edu
- 05.10., 09:30–10:30, NLPHL (Chair)
Martin Hutchings
hutchings@dadlnet.dk
- 05.10., 10:45–12:15, Relapsed & Refractory HL (Speaker)
Wolfram Klapper
wklapper@path.uni-kiel.de
- 04.10., 13:00–14:00, Biology & Pathology (Chair)
- 05.10., 09:30–10:30, NLPHL (Chair)
Ralf Küppers
ralf.kueppers@uk-essen.de
- 04.10., 13:00–14:00, Biology & Pathology (Speaker)
Maurizio Mascarin
- 04.10., 08:00–09:15, HL in Children and Adolescents (Speaker)
Christine Mauz-Körholz
Christine.Mauz-Koerholz@paediat.med.uni-giessen.de
- 04.10., 08:00–09:15, HL in Children and Adolescents (Chair)
Alison Moskowitz
moskowia@mskcc.org
- 05.10., 10:45–12:15, Relapsed & Refractory HL (Speaker)
Craig H. Moskowitz
CHM78@miami.edu
- 05.10., 10:45–12:15, Relapsed & Refractory HL (Chair)
Peter Omondi Oyiro
- 04.10., 08:00–10:00, Closed Workshop on Grassroot Initiative in Classic Hodgkin Lymphoma (Chair)
- 05.10., 08:00–09:15, Special Cases & Situations (Speaker)
GHSG patient representatives
- 04.10., 16:00–17:30, Living Beyond Lymphoma (Speaker)
Maria Cristina Pirosa
maria.pirosa@eoc.ch
- 03.10., 08:30–11:00, Workshop on ctDNA in HL (Chair)
Anne-Sophie Robertz
anne.robertz1@uk-koeln.de
- 05.10., 08:00–09:15, Special Cases & Situations (Speaker)
Gilles Salles
gilles.salles@chu-lyon.fr
- 03.10., 17:00–18:30, Opening Ceremony with Keynote Lecture & Awards (Speaker)
Margaret Shipp
Margaret_Shipp@dfci.harvard.edu
- 04.10., 10:45–12:15, Translating ctDNA into clinical routine (Chair, Speaker)
Christian Steidl
CSteidl@bccancer.bc.ca
Anna Sureda
asureda@iconcologia.net
- 05.10., 10:45–12:15, Relapsed & Refractory HL (Chair)
Hishan Tharmaseelan
hishan.tharmaseelan@uk-koeln.de
- 05.10., 08:00–09:15, Special Cases & Situations (Speaker)
Bastian von Tresckow
Bastian.vonTresckow@uk-essen.de
Joachim Yahalom
yahalomj@mskcc.org
- 03.10., 08:30–11:00, Individualization of Radiation Therapy for Hodgkin Lymphoma (Chair)
Josée Zijlstra
j.zijlstra@amsterdamumc.nl
- 05.10., 08:00–09:15, Special Cases & Situations (Chair)

Past conferences

Return to start screen…

Not Found

Back to start

Program

Speakers / Chairs

Floors

Exhibition

Abstracts

Information

Live

Awards

Information

Information

Information

Archive

14th International Symposium on Hodgkin Lymphoma

Saturday 03.10.2026

Workshop on ctDNA in HL

EHA-LYG/GHSG Joint Session: EHA Clinical Practice Guidelines in Lymphoid Malignancies - From Recommendations to Patient Care

Individualization of Radiation Therapy for Hodgkin Lymphoma

Satellite Symposium 1

Early Stages

Personalized RTx: Focus on RTx Techniques and Late Effect Prediction Models

Just PD1-Inhibition? Early Insights from the GHSG INDIE Trial

Debate: Should Novel Agents Be Integrated Into the Frontline Treatment of Early Stage Low Risk HL Patients?

Oral Abstract Presentations

Satellite Symposium 2

Opening Ceremony with Keynote Lecture & Awards

Keynote Lecture: Changing treatment paradigms in B cell Lymphoma

Poster Session & Welcome Reception

Sunday 04.10.2026

HL in Children and Adolescents

Treatment Evolution in Pediatric Hodgkin Lymphoma: From Research to Real-World Impact

Precision Medicine in Pediatric HL / Harmonized Pediatric HL Protocol in South Africa

Oral Abstract Presentations

Closed Workshop on Grassroot Initiative in Classic Hodgkin Lymphoma

New concepts for the treatment of B-cell lymphomas

DLBCL – The current and future role of ADCs in the context of T-cell engaging therapies

cHL – Treatment strategies for PD-1 inhibition in the relapsed / refractory setting

Translating ctDNA into clinical routine

Circulating Tumor DNA: New insights from the SWOG S1826 study.

Circulating Tumor DNA Analysis for Classification and MRD Assessment – Experience of the German Hodgkin Study Group

Workshop Report

Oral Abstract Presentations

Biology & Pathology

The Biology of HRS Cells

Novel Insights Into the Microenvironment of Hodgkin Lymphoma

Oral Abstract Presentations

Satellite Symposium 4

Living Beyond Lymphoma

Evaluating Late Effects of Contemporary Treatments - Competing Risks & Novel Approaches

Uncertainties with Anti-PD1 & irAE in the First-Line Setting

In Conversation with GHSG Patient Representatives: Building a Bridge Between Cancer Treatment and Everyday Life – Challenges After Lymphoma

Oral Abstract Presentations

Advanced Stages

Unmet Needs and Future Perspectives with BrECADD: Improving Outcomes of HD21

Unmet Needs and Future Perspectives with Nivo-AVD: Unanswered Questions from SWOG S1826

Oral Abstract Presentations

Monday 05.10.2026

Special Cases & Situations

HL in Pregnancy

Critical Organ Failure at Presentation

Anti-PD1 Tx in Pre-Existing Autoimmune Disease

Workshop Report “Grassroot Initiative in Classic Hodgkin Lymphoma”

NLPHL

Clinical Implications of Growth Patterns

Treatment Strategies

Oral Abstract Presentations

Relapsed & Refractory HL

2L Treatment of HL in Era of Novel Agents

Revisiting the Role of Stem Cell Transplantation in rrHL

Unmet Needs and Novel Treatment Approaches in >3L

Oral Abstract Presentations

Best of ISHL14

Best of ISHL14

Farewell

Sponsors

Past conferences

Not Found

14^th International Symposium on Hodgkin Lymphoma